Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant.
Yatharth Hospital & Trauma Care Services Limited (YATHARTH) is listed on the NSE in the Healthcare sector, Medical Care Facilities industry. The YATHARTH share price is ₹1,058.85 (+3.46% today), with a market capitalisation of ₹102B and a price-to-earnings (P/E) ratio of 54.8. MarketRipple tracks the YATHARTH investment thesis, the ripple-chain impact of market events on Yatharth Hospital & Trauma Care Services Limited, and the Healthcare sector outlook.
Open
₹1,056.00
High
₹1,070.00
Low
₹1,045.20
Prev. Close
₹1,023.45
52W High
₹1,184.00
52W Low
₹538.25
Day range
₹1,045.20–₹1,070.00
52-week range
₹538.25–₹1,184.00
Volume
208K
P/E
54.8
ROE
10.0%
D/E
0.15
Margin
12.7%
Yatharth Hospital & Trauma Care Services Limited (NSE: YATHARTH) is currently trading at ₹1,058.85 (+3.46%).
Yatharth Hospital & Trauma Care Services Limited's market capitalization is ₹102B.
Yatharth Hospital & Trauma Care Services Limited's price-to-earnings (P/E) ratio is 54.8.
Yatharth Hospital & Trauma Care Services Limited operates in the Healthcare sector (Medical Care Facilities).
Analyst consensus on Yatharth Hospital & Trauma Care Services Limited currently reads strongly positive, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.